A bone marrow biopsy revealed Hodgkin's lymphoma, and the patient was considered to have clinical-stage IVB disease (Fig. 2â‡“). He underwent treatment with .
Relapsed or refractory Hodgkin lymphoma is a challenging problem for clinicians who treat hematologic malignancies. The standard management of these patients should include the use of salvage chemotherapy followed by autologous stem cell transplant (ASCT) in patients who are chemotherapy sensitive.
mended the disease be classified as Hodgkin's lymphoma (HL). , underlining the fact that therapeutic approaches can benefit from the progress made in other
Relapsed/refractory Hodgkin lymphoma (HL) is still a therapeutic challenge.. Salvage chemotherapy regimens can be divided into intensive conventional .